Creo Medical Group PLC (CREO) - Total Liabilities

Latest as of June 2025: GBX7.90 Million GBX ≈ $961.20 USD

Based on the latest financial reports, Creo Medical Group PLC (CREO) has total liabilities worth GBX7.90 Million GBX (≈ $961.20 USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Creo Medical Group PLC to assess how effectively this company generates cash.

Creo Medical Group PLC - Total Liabilities Trend (2005–2024)

This chart illustrates how Creo Medical Group PLC's total liabilities have evolved over time, based on quarterly financial data. Check CREO asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Creo Medical Group PLC Competitors by Total Liabilities

The table below lists competitors of Creo Medical Group PLC ranked by their total liabilities.

Company Country Total Liabilities
LED iBond International AS
CO:LEDIBOND
Denmark Dkr22.90 Million
Jersey Electricity plc
LSE:JEL
UK GBX125.62 Million
R.E.A. Holdings plc
LSE:RE
UK GBX318.52 Million
Storage Drop Storage Technologies Ltd
TA:STRG
Israel ILA3.25 Million
Montfort Capital Corp
V:MONT
Canada CA$258.24 Million
Newtopia Inc
V:NEWU
Canada CA$13.62 Million

Liability Composition Analysis (2005–2024)

This chart breaks down Creo Medical Group PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Creo Medical Group PLC worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 5.28 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.13 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.11 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Creo Medical Group PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Creo Medical Group PLC (2005–2024)

The table below shows the annual total liabilities of Creo Medical Group PLC from 2005 to 2024.

Year Total Liabilities Change
2024-12-31 GBX22.60 Million
≈ $2.75K
+34.52%
2023-12-31 GBX16.80 Million
≈ $2.04K
-35.22%
2022-12-31 GBX25.93 Million
≈ $3.16K
-4.97%
2021-12-31 GBX27.29 Million
≈ $3.32K
-7.98%
2020-12-31 GBX29.66 Million
≈ $3.61K
+429.58%
2019-12-31 GBX5.60 Million
≈ $681.39
+175.45%
2018-12-31 GBX2.03 Million
≈ $247.37
-11.22%
2018-06-30 GBX2.29 Million
≈ $278.63
+55.67%
2017-06-30 GBX1.47 Million
≈ $178.99
+86.50%
2016-06-30 GBX788.81K
≈ $95.98
+48.05%
2016-02-29 GBX532.79K
≈ $64.83
+80.01%
2015-02-28 GBX295.98K
≈ $36.01
+18.30%
2014-02-28 GBX250.20K
≈ $30.44
+331.38%
2008-02-29 GBX58.00K
≈ $7.06
-76.33%
2007-02-28 GBX245.00K
≈ $29.81
+49.39%
2006-02-28 GBX164.00K
≈ $19.95
+864.71%
2005-02-28 GBX17.00K
≈ $2.07
--

About Creo Medical Group PLC

LSE:CREO UK Medical Devices
Market Cap
$633.60K
GBX5.21 Billion GBX
Market Cap Rank
#30452 Global
#871 in UK
Share Price
GBX12.63
Change (1 day)
-2.88%
52-Week Range
GBX9.90 - GBX17.75
All Time High
GBX243.00
About

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develps CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices deli… Read more